Objective: The objective of this study was to evaluate the effectiveness of two automated medication systems in reducing medication administration errors. Design: The study was a controlled before-and-after study and included three observation periods with collection of data during a 3-week period as initial baseline and two subsequent follow-up periods at 10 and 20 months. Setting: The study was conducted in two Danish acute medical units. Interventions: Two automated medication systems were implemented: (i) a complex automated medication system (cAMS) consisting of an automated dispensing cabinet, automated unit-dose dispensing and barcode medication administration (BCMA) and (ii) a non-patient-specific automated medication system (npsAMS) consisting of automated unit-dose dispensing and BCMA. Main outcome measure: The occurrence of administration errors and sub-types; procedural and clinical errors were observed. The proportion of errors was calculated by dividing the number of doses with one or more errors with the number of opportunities for errors. Difference-in-difference analysis using logistic regression was used to assess changes in proportion of errors. Results: Compared with control, the cAMS reduced the overall risk of administration errors in the intervention unit, (odds ratio (OR) 0.53; 95% confidence interval (CI) 0.27-0.90) and procedural errors were significantly reduced as well (OR 0.44;. The npsAMS effectively reduced the clinical errors in the intervention ward (OR 0.38; 95% CI 0.15-0.96). Conclusions: In line with previous research, this study found that technological interventions in the medication administration process could reduce the occurrence of medication errors.
Introduction
Medication errors have received increased attention in recent decades and are of significant concern to health care organizations globally [1] .
Medication errors occur frequently and adverse events associated with medications are one of the largest causes of harm to hospitalized patients. Reviews have suggested that up to 50% of adverse events in the medication process may be preventable. Thus, the medication administration process is an important area for safety improvements [2] [3] [4] [5] [6] .
Implementation of automated technologies in the medication process may be an important means to reduce medication error rates [7, 8] . Patient identification and alignment with administration records using barcode medication administration (BCMA) in combination with electronic medication administration record (eMAR) have been shown to improve medication safety [9] [10] [11] [12] .
Automated dispensing cabinets (ADCs) are widely implemented in hospital pharmacies in the USA [13] and the implementation of ADCs in hospital departments appears to be increasing [13, 14] . The avoidance of medication errors from ADCs has been sparsely investigated and with varying results [15] , although a recent study showed reduced medication error rates in an Australian emergency department [14] .
Automated dispensing, where medications are packaged either as multi-or unit-dose bags, has shown inconsistent results. Some studies observed a reduction in the number of medication errors [16, 17] although a review by Tsao et al. [18] concluded that the impact of automated dispensing devices might be institution-specific.
Franklin et al. [19] investigated the impact of a closed-loop system combining eMAR, automated dispensing and BCMA and found it to significantly reduce medication administration errors. These results were supported by our recent findings of a patient-specific automated medication system implemented in a Danish hospital [20] .
The objective of this study was to evaluate the effect of two different automated medication systems (AMS) on errors in the medication administration process in a Danish acute medical unit.
Methods

Study design
This prospective, controlled before-and-after study was conducted in two acute medical units from December 2013 to August 2015. The study included three observation periods with collection of data during a 3-week period as initial baseline and two subsequent follow-up periods at 10 and 20 months. The study included implementation of two AMSs. The first system was a complex automated medication system (cAMS), which combined the electronic medication administration record (eMAR), automated drug dispensing, an ADC and BCMA. This system was implemented immediately after the baseline data collection and was in use until the end of the first follow-up data collection. The ADC was subsequently removed from the intervention unit and the second system; a non-patient-specific automated medication system (npsAMS) was implemented. The data for this system were collected in the second follow-up data collection. A detailed description of the different AMSs is provided in Supplementary File 1 and the study outline in Supplementary File 2.
Recruitment
Relevant hospital units were identified based on initial assessment of their clinical tasks, medication profile and duration of stay. Information of the study was given to the potential intervention units and the intervention unit was recruited based on interest. The control unit was recruited to match the intervention unit focusing on similar medication handling procedures and comparable medication profile.
Setting
The hospital pharmacy service at the units was based on ward stock supply where commonly used medications were kept in the local medicine room. The units relied initially on manual medication dispensing and administration. Physicians entered prescriptions directly into the eMAR at the unit after the daily round. The eMAR was used to identify each individual process of medication administration. The specific medication administration procedures at baseline, with cAMS and npsAMS are illustrated in Figs 1-3 .
Data on background characteristics of the units were extracted for three half-year periods to take monthly variations into account: baseline (1 June-30 November 2013), 10-months follow-up (1 June-30 November 2014) and 20-months follow-up (1 June-30 November 2015). Background characteristics are shown in Table 1 .
Definitions
The primary study outcome was the number of errors in the medication administration process. The error rate was determined by dividing the number of doses identified with one or more errors by the number of opportunities for error. The number of opportunities for errors was defined as the total number of doses administered plus doses prescribed but omitted. This method was previously described by Allan and Barkers [21] .
Errors in the medication administration process were defined as the administration of a dose of medication that deviated from the eMAR prescription, from standard hospital policy, or from written procedures. Errors in the medication administration process were further divided into clinical and procedural errors as previously done by Westbrook et al. [22] . Table 2 outlines defined types of errors included in the study. Further details about the local policies and procedures are described in Supplementary material File 3.
Data collection
Measurement of errors was performed by direct observations of nurses in the medication administration process during a 3-week period before implementation and at follow-ups 1 and 2. Observations were done by dedicated pharmaceutical staff with extensive knowledge of the medication used for patients in the acute unit. The observers followed a protocol to ensure reliable and valid observations. They were instructed to intervene only if they observed a severe error during the administration process. A 1-day pilot data collection was used to train the observers, to test the protocol and to align the definition of errors to reduce inter-observer variability.
All observations were recorded on paper-based forms and entered into an Excel spreadsheet (Microsoft Office ver. 2003). Recordings were subsequently compared with the prescribed medication in the eMAR and the written procedures, and any discrepancies were considered errors and categorized according to Table 2 .
Sample size calculation
The number of observations needed was estimated assuming an error rate of 0.22 [7] , the power of 80 and an expected relative reduction in errors of 30%. This indicated a required sample size of 511 doses at each unit and data collection period.
Data analysis
The Excel files were imported into STATA 14. The data sets remained in their original form and all changes, re-coding and generation of new variables were done in script-files to ensure transparency. The number of errors was calculated for each defined error type for the intervention and control ward and the three observation periods.
To estimate the difference in the proportion of errors after implementation of the cAMS and npsAMS, logistic regression was applied with the presence/absence of error as the dependent variable, and time, group and interaction between time and group as the independent variables. A statistical significance level of 0.05 was used. Estimates for the odds ratio (OR) and 95% confidence intervals (CI) for the interaction variable (the 'difference-in-difference' estimate) were considered the primary result for the reduction in errors for the intervention group at follow-ups 1 and 2, evaluating the effects of cAMS and npsAMS, respectively. Moreover, an analysis was performed comparing the two follow-up results to investigate whether a significant difference in the effect of the two AMSs was detected.
Finally, sub-analyses were performed for clinical errors and procedural errors separately.
Ethics
The study was registered and approved by the Danish Data Protection Agency (journal no. 1-16-02-163-12). According to Danish regulations, ethical approval from the National Committee on Health Research Ethics was not required.
Results
A total of 1086 'opportunities for errors' (544 in control ward and 542 in intervention ward) were observed at baseline, 1085 at 10-month follow-up (520 in control ward and 565 in intervention ward) and 1045 at 20-month follow-up (534 in control ward and 511 in intervention ward). Table 3 shows the observed number of errors and the proportion of administered doses with errors. Lack of documentation and wrong strength per unit was the most frequently observed procedural errors. Omission of dose was the most frequently observed clinical error ( Table 3) .
The number of 'doses with one or more errors in the medication administration process' was 126 at baseline (47 in control ward and 79 in intervention ward), 62 at 10-month follow-up (32 in control ward and 30 in intervention ward) and 81 at 20-month follow-up (37 in control ward and 44 in intervention ward) ( Table 4 ). In the intervention ward, the overall proportion of administration errors had decreased from 0.15 to 0.06 at 10-month follow-up and increased to 0.09 at 20-month follow-up. In the control ward, the proportion of administration errors decreased from 0.09 to 0.06 at 10-month followup and to 0.07 at 20-month follow-up (Table 4) . At 10-month followup, this resulted in an overall reduced risk of errors of 47% in the intervention ward compared with the control showing a statistically significant effect of cAMS (OR 0.53; CI 0.27-0.90). A slightly reduced risk of administration errors of 27% was seen at 20-month follow-up measuring the effect of npsAMS; however, this decrease was not statistically significant (OR 0.73; CI 0.40-1.37). No significant difference in total administration errors was found between the two technologies, although implementing npsAMS showed a tendency to a higher risk of administration errors than cAMS (OR 1.44; CI 0.74-2.87).
The sub-analysis showed that the proportion of clinical errors decreased from 0.06 to 0.02 at follow-up 1 and remained 0.02 at follow-up 2 in the intervention ward. In the control ward, the proportion of clinical errors decreased from 0.05 at baseline to 0.02 at 10-month follow-up and increased again to 0.04 at 20-month follow-up. The difference-in-difference analysis showed a significant 62% reduced risk of clinical errors in the intervention ward compared with control at 20-month follow-up (OR 0.38; CI 0.15-0.96), and thereby a positive effect of npsAMS on clinical errors. Non-significant results were seen at 10-month follow-up (cAMS), and when comparing the two technologies. The proportion of procedural errors decreased from 0.10 to 0.04 in the intervention ward at 10-month follow-up and increased again to 0.07 at 20-month follow-up. The proportion of procedural errors remained almost unchanged in the control ward throughout the study period (0.05-0.04-0.04). This resulted in a significant 56% reduced risk of procedural errors in the intervention ward at 10-month followup (OR 0.44, CI 0.16-0.94), showing a positive procedural effect of the cAMS. Non-significant differences were seen at 20-month followup (npsAMS) and when comparing the two technologies.
Discussion
The cAMS (follow-up 1) effectively reduced the proportion of administration errors largely driven by the reduction in the procedural errors. The positive effect for procedural errors was expected, as the nurses were unable to withdraw medication from the ADC unless following the correct procedures. The proportion of clinical errors reduced as well, although non-significantly. A reason why this result was non-significant could be the similar unexplained reduction in the clinical errors seen in the control ward in the same period. Performing a two-sampled t-test with equal variances (before-after comparison without control group) showed statistical significant reduction in clinical errors (P < 0.001).
The results of the npsAMS (20-month follow-up) showed a nonsignificant reduction in the proportion of administration and procedural errors and a significant reduced risk of clinical error in the intervention ward compared with the control ward.
The reduction of the medication administration errors found in our study was similar to the findings in other studies investigating the effect of technological interventions. The Australian study by Fanning et al. [14] investigated the effect of ADC on medication selection and preparation errors in an emergency department, thus, comparable to our setting. The Australian study found a 65-percentage reduction in medication selection and preparation errors; however, the error rates detected in the Australian study were lower than in this present study.
De Young et al. and Helmons et al. [25, 26] investigated the effect of BCMA and found a reduction in the medication administration error rate of 58% and 56%, respectively. Bonkowski et al.
[27] found a relative error rate reduction of 80.7% from implementing an integrated electronic medical record with BCMA.
In a previous study, we found a 57% reduction of medication administration after implementing a closed-loop AMS [20] . In comparison, a French study by Cousein et al. [17] found an overall reduction of medication administration errors by 53% integrating a unit-dose dispensing machine and ADC, and Franklin et al. [19] found an almost 50% reduction of errors implementing a closed-loop medication system.
The results from these previous studies are not directly comparable to our results as they were performed in different settings, testing different interventions or systems and evaluating different error types. These are all important factors questioning the direct comparability of results from the available literature within this area and questioning the comparability of the results from this present study as well. However, the results from our study support the tendency of positive effects of AMSs found in previous studies.
Strengths and limitations of the study
This study was based on a carefully prepared standardized protocol for observations and performed by the same three observers at all times. From the outset, we used clear definitions of errors based on previously published studies [21, 25, 28] . The participating wards were recruited within the same hospital, and observational visits showed that the wards were similar, thus minimizing the risk of confounding factors such as staff stress level and differences in medication profile. To account for potential biases and to ensure the validity of the final results, thorough statistical analyses were performed.
The protocol aimed to ensure that different members of the staff were observed to minimize individual performance influencing the final results. Each different nursing staff was assigned a serial number, and analyses made to investigate the individual impact showed no statistical significance. Because un-blinded pharmaceutical staff performed the observations, this could possibly have introduced bias as they could have an interest in the positive results of the pharmaceutical intervention, thus leading to an overestimation of the effects.
As data were collected by three observers, it could be relevant to compare error rates between observers. However, we did not record observer ID and it was therefore not possible to include the observer as a co-variable in the logistic regression.
The study did not use a disguised technique. The ward nursing staff was told that observations were performed to document changes and effects of the AMS on working procedures and medication safety. This could have influenced the results if the nurses made a greater effort during the medication administration while being observed. However, this potential bias has previously been found to be of limited importance [7] .
The intervention and control ward differed slightly in regards to the background characteristics. The intervention ward expanded from 14 to 17 beds during the study period whereas the control ward maintained the same size. Both wards showed a reduction in the number of nursing staff over time. The average length of stay was lower in the intervention ward than in the control ward and displayed more admissions. Moreover, the occupancy percentage was higher in the intervention ward compared with control. These factors could have influenced the experienced workload among the nursing staff and could possibly influence the results of the study; however, it is difficult to determine how and in which direction. Optimally, the intervention and control ward displayed identical background characteristics as well as no difference in the effect parameter at baseline. In this study, the control ward showed a lower proportion of administration errors than the intervention ward at baseline and experienced a decrease in errors at follow-up 1 and an increase from follow-up 1 to 2. This is, of course, a limitation of the study since this variation in errors was unexpected. It is unclear what caused the lower proportion of errors in the control ward at baseline, but one reason could be the lower occupancy Table 2 Definition of identified error types in the medication administration process [20, 23, 24] Error type Definition
Clinical errors
The patient did not receive the medication as prescribed in the eMAR Wrong drug
The administered drug was not prescribed in the eMAR Omission of dose
The prescribed dose of the drug was not administered to the patient Wrong dose
The administered dose deviated from the prescribed dose Wrong substitution
The substitution was not generic. A drug was substituted by one with another active ingredient Wrong administration form
The form of the administered drug deviated from the eMAR prescription Wrong patient
The administered drugs were given to the wrong patient Procedural errors Deviations from written procedures or guidelines. Deviations could potentially but not necessarily lead to a clinical error Wrong strength per unit
The strength of the administered drug deviated from the prescription in the eMAR E.g. 1 tablet of 100 mg was prescribed in the eMAR but the nurse administered 2 tablets of 50 mg. If this deviation was not documented in the eMAR, it was regarded a procedural error Wrong administration time
The administration time deviated more than 1 h from the eMAR prescription Wrong colour mark in the eMAR If the patient brought medication of his/her own, these should be clearly marked by colour code in the eMAR as well as medication that the patient administer himself/herself. Lack of: Documentation of a substitution A substitution was made but not documented in the eMAR Documentation of the administration The medication was not documented as 'administered' in the eMAR or the clinical reason, if a dose was omitted, was not documented in the eMAR Check of prescription
The nurse did not check the prescription in the eMAR before administering the medicine Barcode scanning a The PDA was not used by the staff during administration eMAR, electronic medication administration record; PDA, personal digital assistant. a Error type only relevant in the intervention ward at follow-up after implementation of the interventions. percentage, more employees and fewer patients; these factors could indicate that the intervention ward experienced a higher workload, which has been found to be an error-provoking condition [29] . What might have caused the variation in errors over time in the control ward remains unclear. However, this could be caused by organizational changes, parallel projects at the control ward focusing on medication safety or perhaps by changes in the nursing staff. The analyses performed in the study were difference-in-difference analyses, which focus n errors, number of observed doses with one or more errors; p errors, proportion of errors; npsAMS, non-patient-specific Automated Medication System; cAMS, complex Automated Medication System; OR, odds ratio; p errors, proportion of errors; 95% CI, confidence interval around the OR. Bold values indicate that 95% CI is below 1 implicitly mean that the result is significant with a P-value below 0.05. In the sub-analysis, the sum of clinical and procedural errors exceeds the number of administration errors. This is due to a number of doses with both a clinical and a procedural error (at the control ward: eight doses at baseline, three doses at follow-up 1 and four doses at follow-up 2; at the intervention ward: 12 doses at baseline and five dose at follow-up 1). npsAMS, non-patient-specific automated medication system; cAMS, complex automated medication system; eMAR, electronic medication administration record. a Lack of barcode scanning was only relevant in the intervention ward at follow-up. This error type was introduced by the intervention and observations where barcode identification was lacking were excluded from the analyses (31 observations and 16 observations were excluded at follow-ups 1 and 2, respectively).
on the change over time between the two groups. In this way, it accounts for the baseline difference between groups as well as the change in the control ward over time and could in, this case, lead to an underestimation of the results.
The intervention unit was not chosen at random but was selected based on interest. It is unclear what motivated the unit but any unforeseen differences in unit culture, management or other organizational factors could have introduced bias into the study findings. Recruitment of two units within the same hospital ensured high comparability but also exposed the control unit to possible influence from the changes undertaken in the intervention ward.
The two AMSs were implemented after each other in the same unit using the same baseline measurements. It is possible that the npsAMS was in favour of effects gained from the cAMS. However, since 20-months follow-up measurements were performed 10 months after change of intervention, this potential gained effect was considered of limited influence on the results.
Conclusion
Two AMSs were implemented in an acute medical unit. The cAMS was significantly effective in reducing the overall administration and the sub-type procedural errors. Although the clinical errors were reduced, the analyses did not show statistical significance. The npsAMS significantly reduced the clinical errors but did not significantly affect the procedural errors.
The results from this study confirm results of previous studies that technological interventions in the medication administration process can reduce the occurrence of medication errors.
